Inhibition of IRP2-dependent reprogramming of iron metabolism suppresses tumor growth in colorectal cancer
Jieon Hwang(Yonsei University), Sang Joon Shin(Yonsei University)
Cited by 16
Related Papers
Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2–Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study
|Journal of Clinical Oncology|2023|100
Quality of life among Korean gastrointestinal cancer survivors
|European Journal of Oncology Nursing|2017|26